Most available drugs are effective for symptom control and structural protection, but they’re not perfect and new agents are being investigated to help close the treatment gap.

A possible first case of COVID recurrence after ensitrelvir: a vaccinated woman whose antigen levels fall and then rebound, with symptoms returning 1 day after treatment.

Recent outbreaks and cruise ship exposures are renewing the debate over whether current Andes virus precautions adequately address possible respiratory spread.

Two KRAS-targeted strategies are starting to reshape treatment for metastatic pancreatic cancer after decades of limited progress with chemotherapy.

A 10-day course of moxifloxacin 400 mg once daily demonstrates superior efficacy to a 6-day course of azithromycin 500 mg once daily for treating Mycoplasma genitalium infection.

FDA-approved EB therapies expand options for gene replacement and wound healing, but success depends on careful wound preparation and timing, experts say.

Patients in the province will be able to seek care at pharmacies for conditions like head lice, nasal congestion, dry eye, and ringworm.

According to a post hoc analysis of patients with juvenile idiopathic arthritis on tofacitinib, younger patients have higher height velocities than expected, and older patients have normal velocities.

In patients with rheumatoid arthritis and preserved kidney function, reduced initial doses of JAK inhibitors show 2-year treatment persistence and disease control similar to those with standard doses.

As more PAs consider retirement, some areas of the country may face shortages, resulting in worse access to healthcare.

More than one third of US adults in the 2024 National Health Interview Survey report experiencing at least one sunburn.

Those are some of the questions dermatologists face when a patient on systemic therapy for psoriasis does not respond fully, when the patient reacts favorably at first but then treatment effectiveness ...